Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07529080 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2027 → Dec 2027
See other at-risk trials from University of Michigan Rogel Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Jul 2026 to Dec 2026
    • Primary and study completion pushed from Aug 2027 to Dec 2027
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: details revised at 4 of 4 entries
  2. Notable Primary and study completion moved earlier from Aug 2029 to Aug 2027
    • Start date: Aug 2026 to Jul 2026
    v3
  3. Notable Start date: Apr 30, 2026 to Aug 2026
    • Primary and study completion pushed from Apr 2029 to Aug 2029
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This pilot clinical trial is intended to compare the effect of a psychosocial support tool for young adult (YA)cancer survivors - including high-quality information about their cancer combined with evidence-based psychosocial support - to a support tool providing cancer-specific information alone (minus psychosocial modules). This tool, called Thrive Track, will be for YA patients aged 20-39 with thyroid, melanoma, or testicular cancer. Young adult survivors frequently experience persistent worry and distress that can interfere with coping and reduce quality of life. They are also particularly vulnerable to the emotional impact of cancer and may not have adequate support to manage these concerns. The enhanced version of Thrive Track includes personalized emotional support content and strategies designed to help patients better manage worry and distress. Adding these emotional support tools may provide greater benefit than survivorship education alone in strengthening young adult survivors' ability to manage their emotional well-being.
Trial Details
NCT Number NCT07529080
Lead Sponsor University of Michigan Rogel Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)
Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm, Melanoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma
Related terms Adenocarcinoma, Follicular, Melanoma, Testicular Neoplasms, Thyroid Cancer, Papillary
Enrollment 142 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov